Suven Life Sciences Limited (BOM: 530239)
India
· Delayed Price · Currency is INR 119.80
-0.80 (-0.66%)
At close: Nov 14, 2024
Suven Life Sciences Revenue
Suven Life Sciences had revenue of 25.73M INR in the quarter ending September 30, 2024, a decrease of -15.91%. This brings the company's revenue in the last twelve months to 84.15M, down -32.82% year-over-year. In the fiscal year ending March 31, 2024, Suven Life Sciences had annual revenue of 116.93M, down -13.99%.
Revenue (ttm)
84.15M
Revenue Growth
-32.82%
P/S Ratio
n/a
Revenue / Employee
596.80K
Employees
141
Market Cap
26.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 116.93M | -19.02M | -13.99% |
| Mar 31, 2023 | 135.95M | 16.44M | 13.76% |
| Mar 31, 2022 | 119.51M | -21.23M | -15.08% |
| Mar 31, 2021 | 140.73M | -6.32M | -4.30% |
| Mar 31, 2020 | 147.05M | -2.71B | -94.86% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSuven Life Sciences News
- 2 months ago - Suven Life Sciences reports positive Phase-2a results for Ropanicant in treating Major Depressive Disorder - Business Upturn
- 2 months ago - Suven Life Sciences announces FDA acceptance of Investigational New Drug - Business Upturn